Literature DB >> 9934689

Localization of isoprenylated antigen of hepatitis delta virus by anti-farnesyl antibodies.

H P Lin, S C Hsu, J C Wu, I J Sheen, B S Yan, W J Syu.   

Abstract

Hepatitis delta virus (HDV) is a subviral pathogen that requires pre-existing or concurrent infection with hepatitis B virus (HBV). HDV expresses two forms of a single protein, the delta antigen (HDAg), which are identical except for an additional 19 residues at the C terminus of the large form. Within this C-terminal extension a cysteine residue is isoprenylated; this isoprenylation is critical for interaction with HBV envelope proteins to enable virus assembly and release into the medium. Therefore, large HDAg must be recruited to an extracellular compartment. However, immuno-staining with HDAg-specific antibodies has localized the large antigen mainly to the nucleus and supports the notion that large HDAg suppresses virus replication in the nucleus. Since isoprenylation would increase the hydrophobicity of the protein and may favour transport towards specific membranes, the question remains whether the large HDAg detected in the nucleus carries an isoprenyl group. To address this issue, antibodies against the farnesyl modification were generated to allow direct visualization of the antigen by immunofluorescence microscopy. The anti-farnesyl antibodies specifically stained large HDAg expressed in Huh-7 cells, and the signal was largely restricted to the nucleus; the staining pattern could be superimposed on those of cells stained for large HDAg. The large HDAg translocated into the nucleus was therefore isoprenylated. In addition, antibodies specific for the farnesyl modification should be applicable to the study of other similarly isoprenylated proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9934689     DOI: 10.1099/0022-1317-80-1-91

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Unique properties of the large antigen of hepatitis delta virus.

Authors:  G Moraleda; S Seeholzer; V Bichko; R Dunbrack; J Otto; J Taylor
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Prenylation of Saccharomyces cerevisiae Chs4p Affects Chitin Synthase III activity and chitin chain length.

Authors:  Kariona A Grabińska; Paula Magnelli; Phillips W Robbins
Journal:  Eukaryot Cell       Date:  2006-12-01

3.  Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus.

Authors:  Chi-Ruei Huang; Szecheng John Lo
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 4.  Synthetic isoprenoid analogues for the study of prenylated proteins: Fluorescent imaging and proteomic applications.

Authors:  Yen-Chih Wang; Mark D Distefano
Journal:  Bioorg Chem       Date:  2015-12-10       Impact factor: 5.275

5.  The pseudorabies virus Us2 protein, a virion tegument component, is prenylated in infected cells.

Authors:  Amanda C Clase; Mathew G Lyman; T del Rio; Jessica A Randall; Christine M Calton; L W Enquist; Bruce W Banfield
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  Multifunctional reagents for quantitative proteome-wide analysis of protein modification in human cells and dynamic profiling of protein lipidation during vertebrate development.

Authors:  Malgorzata Broncel; Remigiusz A Serwa; Paulina Ciepla; Eberhard Krause; Margaret J Dallman; Anthony I Magee; Edward W Tate
Journal:  Angew Chem Int Ed Engl       Date:  2015-03-25       Impact factor: 15.336

7.  Metabolic labeling with an alkyne probe reveals similarities and differences in the prenylomes of several brain-derived cell lines and primary cells.

Authors:  Kiall F Suazo; Angela Jeong; Mina Ahmadi; Caroline Brown; Wenhui Qu; Ling Li; Mark D Distefano
Journal:  Sci Rep       Date:  2021-02-23       Impact factor: 4.379

8.  Varied immunity generated in mice by DNA vaccines with large and small hepatitis delta antigens.

Authors:  Yi-Hsiang Huang; Jaw-Ching Wu; Sheng-Chieh Hsu; Wan-Jr Syu
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.